Inflammatory factors such as interleukin-6 (IL-6), tumor necrosis factor (TNF)-α, and leukemia inhibitory factor (LIF) are commonly examined for their roles in cancer-induced muscle wasting (Carson and Baltgalvis, 2010; Patel and Patel, 2017). This evidence concerns the gene IL6 and cancer.